Position in PTCT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,212,154
-$2,702,578 QoQ
Shares Held
164,570
-10.2% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99.76301877620466.ToString("F0")%
Shared 0.ToString("F0")%
None 0.23698122379534545.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $507,759,030 across 170 Biotechnology names. PTCT ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,491 | $108,548,965 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,560 | $58,746,801 | |
| 3 | INCY |
Incyte Corp
|
374,280 | $35,227,233 | |
| 4 | EXEL |
Exelixis, Inc.
|
463,825 | $19,893,454 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
64,133 | $12,804,153 | |
| 6 | ALMS |
Alumis Inc.
|
538,733 | $11,868,287 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
This page
|
164,570 | $11,212,154 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
95,235 | $10,037,769 |
All Filings in PTCT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,212,154 | 164,570 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $13,914,732 | 183,185 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,366,192 | 87,440 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,114,770 | 84,250 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,169,202 | 62,190 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $253,686 | 5,620 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $220,745 | 5,950 | Shares | Defined | 2024-11-14 | |
| 2023-06-30 | $237,227 | 5,833 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $275,187 | 5,681 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,869,820 | 153,781 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,265,279 | 164,647 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $7,496,427 | 187,130 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,452,372 | 199,742 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,417,396 | 136,013 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,627,212 | 124,354 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,512,890 | 83,106 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,782,967 | 227,729 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $12,504,008 | 204,883 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $43,197 | 924 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $17,809 | 351 | Shares | Defined | 2021-08-05 | |
| 2020-03-31 | $13,383 | 300 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||